Denali Therapeutics Down After Proposing To Sell $250 Million Of Shares
Shares of Denali Therapeutics Inc. (DNLI) are falling more than 9% Wednesday morning at $29.60.
The company today said it proposes offer for sale of $250 million of shares.
DNLI has traded in the range of $20.24-$56.08
in the last 52 weeks.
Source: Read Full Article